We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

Play the video to learn more
This is exactly what has been replicated, to some extent, in the most recent consensus from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). And, in fact, if you look at the most famous flow chart for treatment, what has been identified as specific needs for a patient is the identification of those with a cardiovascular risk or people who have already had a prior cardiovascular event, people for whom the most compelling issue is the reduction or avoidance of hypoglycaemia, and those for whom body weight may be the key factor. And, finally, the potential cost, and the societal implication of that cost, of the drugs needs to be considered. So the overall idea behind all this is the fact that we need to move towards treatments that are centred on needs of the patient.

For more on the ADA/EASD consensus statement, visit our module on the 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the ADA and the EASD.

 

Select image for larger view

To download or view this diagram in a new tab, click this link


Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018 Dec;61(12):2461-2498.
http://www.ncbi.nlm.nih.gov/pubmed/30288571

2019 update to: Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio DA, Davies MJ. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020 Feb;63(2):221-228.